News · 26 weeks20%
2025-12-142026-06-07
Mix190d
- Other1(100%)
Latest news
25 items- PRSonder Capital Closes its Second Fund and Announces Participation from Major Healthcare SystemsSAN CARLOS, Calif., March 24, 2026 /PRNewswire/ -- Sonder Capital, a healthcare venture capital firm investing in companies revolutionizing the standard of care, today announced the closing of its second fund, Futures II. The fund includes participation from Mayo Clinic and Sutter Health, reflecting their collective interest in innovative technologies that have the potential to advance the future of patient care by enhancing access, improving quality and transforming the overall patient experience."Through our second fund we'll continue enabling the next wave of companies and he
- PRPulse Biosciences, Inc. Appoints Maria Sainz to its Board of DirectorsPulse Biosciences, Inc. (NASDAQ:PLSE), a company leveraging its novel nPulse™ technology using its proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA™) energy, today announced the appointment of Maria Sainz to its Board of Directors effective as of January 9, 2026. "We are delighted to welcome Maria to our Board of Directors," said Pulse Biosciences' Co-Chairman of the Board Robert W. Duggan. "She brings an exceptionally strong track record of guiding both public and private medical device companies through growth, commercialization, viability, and scale. Her strategic and operational expertise will be invaluable as Pulse begins creating and disrupting interventional m
- PRBruker Appoints Laura Francis to its Board of DirectorsBruker Corporation (NASDAQ:BRKR) today announced that its Board of Directors has appointed Laura Francis to serve on its board as an independent director, effective as of February 18, 2025. Ms. Francis is also expected to join Bruker's Audit Committee as a financial expert after Bruker's annual shareholder meeting at the end of May 2025. Laura Francis is the Chief Executive Officer and a Board Member of SI-BONE, Inc. (NASDAQ:SIBN), a medical device company solving musculoskeletal disorders of the sacropelvic anatomy. She was previously the Chief Financial Officer and Chief Operating Officer of the company. Prior to joining SI-BONE, Ms. Francis held other executive and leadership roles with
- PRDeborah Kilpatrick Joins Sonder Capital as its Newest Venture PartnerSAN CARLOS, Calif., Oct. 28, 2024 /PRNewswire/ -- Sonder Capital, a leading healthcare venture firm focused on innovative technologies ushering in a new standard of care in medicine, announced the addition of Deborah Kilpatrick, Ph.D., former CEO of Evidation Health and co-founder of MedtechWomen, as a Venture Partner. Kilpatrick earned her Ph.D. from Georgia Tech in mechanical engineering with a focus in bioengineering and a minor in applied mathematics. Most recently, she was the CEO and Executive Chair of the Board at Evidation Health, a technology company that pioneered th
- SECSEC Form 15-12G filed by Shockwave Medical Inc.15-12G - Shockwave Medical, Inc. (0001642545) (Filer)
- INSIDERFrancis Laura returned 4,784 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - Shockwave Medical, Inc. (0001642545) (Issuer)
- INSIDERMoll Frederic H returned 287,521 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - Shockwave Medical, Inc. (0001642545) (Issuer)
- INSIDERPapiernik Antoine returned 34,913 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - Shockwave Medical, Inc. (0001642545) (Issuer)
- INSIDERSainz Maria returned 5,328 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - Shockwave Medical, Inc. (0001642545) (Issuer)
- SECSEC Form S-8 POS filed by Shockwave Medical Inc.S-8 POS - Shockwave Medical, Inc. (0001642545) (Filer)
- INSIDERToyloy Sara returned 3,673 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - Shockwave Medical, Inc. (0001642545) (Issuer)
- INSIDERWatkins Frank T returned 4,532 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - Shockwave Medical, Inc. (0001642545) (Issuer)
- INSIDERPhung Trinh returned 50,387 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - Shockwave Medical, Inc. (0001642545) (Issuer)
- INSIDERLarkin C Raymond Jr returned 5,281 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - Shockwave Medical, Inc. (0001642545) (Issuer)
- SECSEC Form S-8 POS filed by Shockwave Medical Inc.S-8 POS - Shockwave Medical, Inc. (0001642545) (Filer)
- INSIDERBallinger Kevin J. returned 1,733 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - Shockwave Medical, Inc. (0001642545) (Issuer)
- INSIDERGaeta Renee returned 19,890 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - Shockwave Medical, Inc. (0001642545) (Issuer)
- INSIDERZacharias Isaac returned 56,288 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - Shockwave Medical, Inc. (0001642545) (Issuer)
- SECSEC Form S-8 POS filed by Shockwave Medical Inc.S-8 POS - Shockwave Medical, Inc. (0001642545) (Filer)
- INSIDERGodshall Douglas Evan returned 151,629 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - Shockwave Medical, Inc. (0001642545) (Issuer)
- SECSEC Form S-8 POS filed by Shockwave Medical Inc.S-8 POS - Shockwave Medical, Inc. (0001642545) (Filer)
- SECSEC Form S-8 POS filed by Shockwave Medical Inc.S-8 POS - Shockwave Medical, Inc. (0001642545) (Filer)
- SECSEC Form S-8 POS filed by Shockwave Medical Inc.S-8 POS - Shockwave Medical, Inc. (0001642545) (Filer)
- SECSEC Form POSASR filed by Shockwave Medical Inc.POSASR - Shockwave Medical, Inc. (0001642545) (Filer)
- SECShockwave Medical Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control of Registrant, Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Entry into a Material Definitive Agreement, Events That Accelerate or Increase a Direct Financial Obligation, Regulation FD Disclosure8-K - Shockwave Medical, Inc. (0001642545) (Filer)
SWAV FAQ
7 questionsWhat does Shockwave Medical Inc. do?
ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology to treat calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease; C2 catheters for treating coronary artery disease; and S4 catheters for treating below-the-knee peripheral artery disease. It serves interventional cardiologists, vascular surgeons, and interventional radiologists through sales representatives and sales managers...Where does SWAV stock trade?
Shockwave Medical Inc. (SWAV) is listed on NASDAQ.What sector and industry is SWAV in?
Shockwave Medical Inc. operates in the Health Care sector, Medical/Dental Instruments industry.When did Shockwave Medical Inc. go public?
Shockwave Medical Inc. (SWAV) completed its IPO in 2019.What are analysts saying about SWAV?
Shockwave Medical Inc. has had 8 recent analyst actions on file. The most recent action was from Wolfe Research: Peer Perform on 2024-04-05.What companies are similar to SWAV?
Notable peers in the same industry include SYK (Stryker Corporation), MMM (3M Company), BSX (Boston Scientific Corporation), MDLN (Medline Inc.), BDX (Becton Dickinson and Company). Compare SWAV side-by-side with any of them on Quantisnow.How can I track SWAV on Quantisnow?
Quantisnow aggregates Shockwave Medical Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow SWAV to receive live email and push alerts on every new disclosure.